FDA Inspection 737328 — AstraZeneca Pharmaceuticals, LP

AstraZeneca Pharmaceuticals, LP — FEI 2517100

The FDA completed an inspection of AstraZeneca Pharmaceuticals, LP on July 5, 2011 in Newark, DE. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 5, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Newark, DE (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures